-

Philip Morris International Discusses Its Marketing Practices

STAMFORD, Conn.--(BUSINESS WIRE)--Moira Gilchrist, Global Chief Communications Officer at Philip Morris International (PMI), clarifies company’s marketing practices and facts related to ZYN nicotine pouches.

Contacts

Philip Morris International
Travis Parman
Philip Morris International
T. +1 (475) 550-2737
E. travis.parman@pmi.com

Philip Morris International

NYSE:PM

Release Versions

Contacts

Philip Morris International
Travis Parman
Philip Morris International
T. +1 (475) 550-2737
E. travis.parman@pmi.com

More News From Philip Morris International

Philip Morris International Expands its Partnership with Scuderia Ferrari HP, Launching a Bold New Chapter in Their Long-Standing Relationship

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today announced an expanded partnership with Scuderia Ferrari HP and with Ferrari Challenge Trofeo Pirelli—the single-marque motorsport championship created in 1993—for the 2026 season and beyond. This next chapter introduces one major development: the ZYN brand of nicotine pouches—the number one nicotine pouch brand globally1—will feature on Scuderia Ferrari HP Formula 1 liveries at select races throughout the seasons....

Philip Morris International Publishes Updated Climate Transition Plan to Achieve Net Zero by 2040

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced the release of its second Climate Transition Plan (CTP 2025), presenting an updated and integrated strategy to achieve net-zero greenhouse gas (GHG) emissions across its value chain by 2040. The new plan reflects PMI’s continued commitment to a low-carbon future while aligning with science, regulatory frameworks, and stakeholder expectations, and builds on its 2021 Low-Carbon Transition Plan. Furthe...

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

STAMFORD, CT--(BUSINESS WIRE)--Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP). The full-day meeting on October 7 was part of the FDA’s customary review of PMI’s request to continue marketing versions of its IQOS heated tobac...
Back to Newsroom